Can the "three tumor markers" detect cancer?
Tumor marker panel three primarily refers to alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), and carbohydrate antigen CA125. Under normal circumstances, this panel can detect tumors; however, it may fail to identify early-stage tumors. Specific analysis is as follows:
1. Yes: When a tumor is present, the associated tumor markers usually increase. Therefore, if a patient's tumor marker levels are significantly higher than the normal range, this may indicate the presence of a tumor. For individuals with a family history of cancer or other high-risk factors, the tumor marker panel three can be used for early screening to detect potential tumors sooner.
2. No: Tumor markers typically rise only when the tumor is relatively large or has advanced. Thus, in the case of early-stage tumors, these markers may not be elevated enough to allow detection.
If there are any concerns regarding the above, it is recommended to consult a doctor for medical advice.